Novavax, Inc. (NASDAQ:NVAX) At $13.65: What To Do?

In recent trading session, Novavax, Inc. (NASDAQ:NVAX) saw 6.28 million shares changing hands at last check today with its beta currently measuring 2.00. Company’s recent per share price level of $13.65 trading at -$1.4 or -9.31% at last check today assigns it a market valuation of $1.92B. That most recent trading price of NVAX’s stock is at a discount of -74.8% from its 52-week high price of $23.86 and is indicating a premium of 74.14% from its 52-week low price of $3.53. Taking a look at company’s average trading volume volume of 14.53 million if we extend that period to 3-months.

Novavax, Inc. (NASDAQ:NVAX) trade information

Upright in the red during last session for losing -9.31%, in the last five days NVAX remained trading in the red while hitting it’s week-highest on Monday, 06/10/24 when the stock touched $13.65 price level, adding 23.57% to its value on the day. Novavax, Inc.’s shares saw a change of 184.36% in year-to-date performance and have moved -24.88% in past 5-day. Novavax, Inc. (NASDAQ:NVAX) showed a performance of 5.81% in past 30-days.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Novavax, Inc. (NVAX) estimates and forecasts

Statistics highlight that Novavax, Inc. is scoring comparatively higher than the scores of other players of the relevant industry. The company added 154.65% of value to its shares in past 6 months, showing an annual growth rate of 106.84% while that of industry is 15.70. Apart from that, the company came raising its revenue forecast for fiscal year 2024. This year revenue growth is estimated to rise 1.20% from the last financial year’s standing.

4 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 414.82M for the same. And 4 analysts are in estimates of company making revenue of 51.45M in the next quarter.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 11.55% during past 5 years. In 2024, company’s earnings growth rate is likely to be around 107.92% while estimates for its earnings growth in next 5 years are of 37.90%.

NVAX Dividends

Novavax, Inc. is more likely to be releasing its next quarterly report in July and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.